Karns Michael R, Jones Daniel L, Todd Dane C, Maak Travis G, Aoki Stephen K, Burks Robert T, Yoo Minkyoung, Nelson Richard E, Greis Patrick E
Department of Orthopaedics, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Department of Orthopaedics, University of Utah Orthopaedic Center, University of Utah, Salt Lake City, Utah, USA.
Orthop J Sports Med. 2018 Aug 6;6(8):2325967118788543. doi: 10.1177/2325967118788543. eCollection 2018 Aug.
Few studies have investigated the influence of patient-specific variables or procedure-specific factors on the overall cost of anterior cruciate ligament reconstruction (ACLR) in an ambulatory surgery setting.
To determine patient- and procedure-specific factors influencing the overall direct cost of outpatient arthroscopic ACLR utilizing a unique value-driven outcomes (VDO) tool.
Cohort study (economic and decision analysis); Level of evidence, 3.
All ACLRs performed by 4 surgeons over 2 years were retrospectively reviewed. Cost data were derived from the VDO tool. Patient-specific variables included age, body mass index, comorbidities, American Society of Anesthesiologists (ASA) classification, smoking status, preoperative Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Computerized Adaptive Testing (PF-CAT) score, and preoperative Single Assessment Numeric Evaluation (SANE) score. Procedure-specific variables included graft type, revision status, associated injuries and procedures, time from injury to ACLR, surgeon, and operating room (OR) time. Multivariate analysis determined patient- and procedure-related predictors of total direct costs.
There were 293 autograft reconstructions, 110 allograft reconstructions, and 31 hybrid reconstructions analyzed. Patient-specific factors did not significantly influence the ACLR cost. The mean OR time was shorter for allograft reconstruction ( < .001). Predictors of an increased direct cost included the use of an allograft or hybrid graft (44.5% and 33.1% increase, respectively; < .001), increased OR time (0.3% increase per minute; < .001), surgeon 3 or 4 (9.1% or 5.9% increase, respectively; < .001 or = .001, respectively), and concomitant meniscus repair (24.4% increase; < .001). Within the meniscus repair cohort, all-inside, root, and combined repairs correlated with a 15.5%, 31.4%, and 53.2% increased mean direct cost, respectively, compared with inside-out repairs ( < .001).
This study failed to identify modifiable patient-specific factors influencing direct costs of ACLR. Allografts and hybrid grafts were associated with an increased total direct cost. Meniscus repair independently predicted an increased direct cost, with all-inside, root, and combined repairs being costlier than inside-out repairs. The time-saving potential of all-inside meniscus repair was not realized in this study, making implant use a significant factor in the overall cost of ACLR with meniscus repair.
在门诊手术环境中,很少有研究调查患者特定变量或手术特定因素对前交叉韧带重建(ACLR)总成本的影响。
利用独特的价值驱动结果(VDO)工具,确定影响门诊关节镜下ACLR直接总成本的患者和手术特定因素。
队列研究(经济和决策分析);证据等级为3级。
回顾性分析4位外科医生在2年内进行的所有ACLR手术。成本数据来自VDO工具。患者特定变量包括年龄、体重指数、合并症、美国麻醉医师协会(ASA)分级、吸烟状况、术前患者报告结果测量信息系统(PROMIS)身体功能计算机自适应测试(PF-CAT)评分和术前单一评估数字评价(SANE)评分。手术特定变量包括移植物类型、翻修状态、相关损伤和手术、受伤至ACLR的时间、外科医生和手术室(OR)时间。多变量分析确定了直接总成本的患者和手术相关预测因素。
共分析了293例自体移植物重建、110例同种异体移植物重建和31例混合重建。患者特定因素对ACLR成本没有显著影响。同种异体移植物重建的平均OR时间较短(P<0.001)。直接成本增加的预测因素包括使用同种异体移植物或混合移植物(分别增加44.5%和33.1%;P<0.001)、OR时间增加(每分钟增加0.3%;P<0.001)、外科医生3或4(分别增加9.1%或5.9%;分别为P<0.001或P=0.001)以及同时进行半月板修复(增加24.4%;P<0.001)。在半月板修复队列中,与由外向内修复相比,全内修复、根部修复和联合修复的平均直接成本分别增加了15.5%、31.4%和53.2%(P<0.001)。
本研究未能确定影响ACLR直接成本的可改变患者特定因素。同种异体移植物和混合移植物与直接总成本增加相关。半月板修复独立预测直接成本增加,全内修复、根部修复和联合修复比由外向内修复成本更高。本研究未实现全内半月板修复的省时潜力,使植入物的使用成为半月板修复ACLR总成本的一个重要因素。